S
← US Companies

LOCKHEED MARTIN CORP

LMT · NYSE · CIK 0000936468

SIC 3760

Guided Missiles & Space Vehicles & Parts

Category

Transportation Equipment

Entity

operating

Incorp.

MD

Fiscal Y/E

1231

Source: SEC EDGAR · All filings on SEC →

Business Overview

Source: SEC 10-K

3 ITEM 1A. Risk Factors 10 ITEM 1B. Unresolved Staff Comments 23 ITEM 1C. Cybersecurity 23 ITEM 2. Properties 24 ITEM 3. Legal Proceedings 25 ITEM 4. Mine Safety Disclosures 25 Information about our Executive Officers 25 PART II ITEM 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 27 ITEM 6. [Reserved] 28 ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 29 ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk 49 ITEM 8. Financial Statements and Supplementary Data 50 ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 93 ITEM 9A. Controls and Procedures 93 ITEM 9B. Other Information 95 ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 95 PART III ITEM 10. Directors, Executive Officers and Corporate Governance 95 ITEM 11. Executive Compensation 95 ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 96 ITEM 13. Certain Relationships and Related Transactions, and Director Independence 96 ITEM 14. Principal Accounting Fees and Services 96 PART IV ITEM 15. Exhibits and Financial Statement Schedules 97 ITEM 16. Form 10-K Summary 101 SIGNATURES 102 Table of Contents PART I ITEM 1. Business General We are a global aerospace and defense technology company that builds and sustains the solutions America and its allies need to deter conflict and advance national security and scientific exploration objectives. Our four business areas – Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, and Space – work as one company offering integrated solutions, at scale, across all warfighting domains. Our defense, space, intelligence, homeland security, information technology, and cybersecurity capabilities serve U.S. and international customers in defense, civil and commercial applications. Our principal customers are agencies of the U.S. Government and allies. Recent regional conflicts have demonstrated the integral role Lockheed Martin products play in protecting people, and we are rapidly transforming our business to meet increased demand. We are expanding production capacity to continue delivering at scale, and we are harnessing leading-edge technologies like artificial intelligence and autonomy, open-architecture systems, and advanced networking to make defense forces more agile, adaptive and unpredictable. Our goal is to deliver overwhelming capability and value – quickly, at the needed quantities and with the greatest effectiveness – to enable overmatch and strengthen deterrence today and into the future. We achieve this by developing and investing in differentiating technologies, forging strategic partnerships, including with commercial companies, executing on our multi-year business transformation initiative, maintaining fiscal discipline, and continuing to cultivate the greatest aerospace and defense workforce talent and culture in the world. We invest substantially in our people to ensure that our people have the technical skills necessary to succeed, and we expect to continue to invest internally in innovative technologies that address rapidly evolving mission requirements for our customers. We also will continue to evaluate our organizational structure and portfolio and will make strategic changes, acquisitions or divestitures, as appropriate, while deepening our connection to commercial industry through cooperative partnerships, joint ventures and equity investments. Business Segments We operate in four business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS) and Space. We organize our business segments based on the nature of the products and services offered. Aeronautics Aeronautics is engaged in the research, design, development, manufacture, integration, sustainment, support and upgrade of advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles and related technologies. Aeronautics also has contracts with the U.S. Government for various classified programs. Aeronautics' major programs include: • F-35 Lightning II – international multi-role, multi-variant, fifth generation stealth fighter. • C-130 Hercules – international tactical airlifter. • F-16 Fighting Falcon – combat-proven, international multi-role fighter. • F-22 Raptor – air dominance and multi-role fifth generation stealth fighter. The F-35 program is our largest program, generating 27% of our total consolidated sales, as well as 67% of Aeronautics' sales in 2025. The F-35 program consists of multiple development, production and sustainment contracts. Development is focused on modernizing F-35's capability and addressing emerging threats. Sustainment provides logistics and training support for the aircraft delivered to F-35 customers. Aircraft production is expected to continue well into the future gi

Investment Indicators

$565.62

+9.10 (+1.64%)

Open

$559.00

High

$569.96

Low

$556.45

Prev Close

$556.52

Volume

843,004

52W High

$692.00

52W Low

$401.93

50-day MA

$580.44

Quote as of: 2026-08-26

ROE

74.65%

Total Shareholder Yield

5.05%

Market Cap

$120.49B

P/E

25.50

P/B

16.21

PEG

1.11

EPS

20.49

BPS

32.56

Dividend Yield

2.56%

Beta

0.10

ROA

8.38%

D/E Ratio

7.90

Current Ratio

1.09

Gross Margin

10.15%

Operating Margin

10.30%

Net Margin

6.69%

Book Value/Share

$29.35

Intrinsic Value Estimates

Multiple valuation methods, each with its own assumptions — outputs can diverge widely

Median consensus (7 methods)

$42.64B

Deep overvalued +182.5%

Per-method implied market cap

Current market cap$120.49B
현재
Graham Number+337%
$27.54B
Graham Formula+183%
$42.64B
Justified P/E+60%
$75.25B
P/B 배수+1095%
$10.08B
P/S 배수-20%
$150.10B
DCF (Gordon)+27%
$95.08B
DDM (Gordon)+246%
$34.79B
Bar tintDeep undervaluedUndervaluedFairOvervaluedDeep overvalued
MethodImplied market capvs current

Graham Number

√(22.5 × 순이익 × 자본)

$27.54B+337%

Graham Formula

순이익 × (8.5 + 2 × 성장률%)

$42.64B+183%

Justified P/E

순이익 × 산업 평균 P/E

$75.25B+60%

P/B 배수

자본 × 산업 평균 P/B

$10.08B+1095%

P/S 배수

매출 × 산업 평균 P/S

$150.10B-20%

DCF (Gordon)

CF × (1+g) / (r − g)

$95.08B+27%

DDM (Gordon)

D × (1+g) / (r − g)

$34.79B+246%
Detailed analysis — formula walk-through & scenarios

Why this conclusion

Of the 7 valuation methods, 7 were applicable. Their median fair-value lands +182.5% below the current market cap → the stock trades above most formulas' estimates (overvalued). 6 methods flag overvalued, 1 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.

Graham Number

Overvalued +337.4%

√(22.5 × 순이익 × 자본)

What it measures · Benjamin Graham's conservative safety-margin formula. A high value requires both earnings and equity to be solid, so read it as 'the ceiling for a financially intact company.'

How it is computed · √(22.5 × NetIncome × Equity). 22.5 = max P/E 15 × max P/B 1.5 Graham would pay. Net income is latest FY consolidated net income from DART/XBRL; equity is total equity from the same filing.

When to trust it · Best for stable profitable industrials. Underestimates SaaS/platform/biotech because intangible-heavy businesses carry little book equity.

Current

$120.49B

Implied fair

$27.54B

Gap (current − fair)

+$92.95B(+337.4%)

NetIncome = $5.02B
Equity = $6.72B
√(22.5 × $5.02B × $6.72B) = $27.54B
  • 최대 PER 15배
  • 최대 PBR 1.5배
  • 안정적 흑자 기업 가정 (금융·고성장 부정확)

Graham Formula

Overvalued +182.5%

순이익 × (8.5 + 2 × 성장률%)

What it measures · Graham's 1962 revision that bakes growth into the multiple. Unlike the static Graham Number, this scales linearly with EPS growth so growth stocks aren't punished as hard.

How it is computed · NetIncome × (8.5 + 2g). 8.5 = base P/E for a zero-growth firm; 2g = +2× P/E for every 1pp of EPS growth. g is YoY EPS growth, clamped to [-5%, +25%] so a single big year doesn't blow up the estimate.

When to trust it · Works for firms with proven, somewhat stable growth. Misleading for first-year profits, swing years, or any period where g is distorted by a one-time charge or gain.

Current

$120.49B

Implied fair

$42.64B

Gap (current − fair)

+$77.85B(+182.5%)

NetIncome = $5.02B
Growth g = -6.0% → cap -5.0%
Multiple = 8.5 + 2 × -5.0 = -1.5×
$5.02B × -1.5 = $-7.53B
  • EPS 성장률 -6.0%/년 가정 (직전 1년 기준)
  • 무성장 기업 P/E = 8.5
  • 현재 적용 배수: 8.5x

Justified P/E

Overvalued +60.1%

순이익 × 산업 평균 P/E

What it measures · Relative-value benchmark — "should trade at the industry average P/E." Not an absolute intrinsic value; tells you how the firm prices vs its peer set.

How it is computed · NetIncome × industry P/E. Defaults to a market-wide 15× when no industry multiple is provided. Net income is the latest FY consolidated net income.

When to trust it · Most reliable in mature industries with comparable peers (banks, telcos, utilities, refiners). Less useful for big-tech / hardware where industry P/Es span 10×–60×.

Current

$120.49B

Implied fair

$75.25B

Gap (current − fair)

+$45.24B(+60.1%)

NetIncome = $5.02B
Industry P/E = 15×
$5.02B × 15 = $75.25B
  • 산업 평균 PER 15x 가정 (사용자 정의 가능)
  • 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장

P/B 배수

Overvalued +1095.2%

자본 × 산업 평균 P/B

What it measures · Multiplies book equity by industry P/B to imply a fair market cap. Best for asset-heavy businesses (banks, insurers, brokers, REITs) where balance-sheet value is the franchise.

How it is computed · Total Equity × industry P/B. Defaults to 1.5×. Equity is total equity (or parent-owners share) from the latest balance sheet.

When to trust it · Strongest for banks/insurers — asset-liability matching is the business. Materially under-prices SaaS, platforms, and brand-heavy businesses where intangible value dwarfs book equity.

Current

$120.49B

Implied fair

$10.08B

Gap (current − fair)

+$110.41B(+1095.2%)

Equity = $6.72B
Industry P/B = 1.5×
$6.72B × 1.5 = $10.08B
  • 산업 평균 PBR 1.5x 가정
  • 은행·보험·자산집약적 산업에 특히 유효

P/S 배수

Undervalued -19.7%

매출 × 산업 평균 P/S

What it measures · Multiplies revenue by industry P/S. Useful when earnings are negative or noisy (early-stage, restructuring) — revenue stays positive.

How it is computed · Revenue × industry P/S. Defaults to 2.0×. Revenue is the latest FY consolidated top line.

When to trust it · Ignores margin structure — a 30% operating margin business and a -5% one get the same multiple. Only meaningful within peer + margin cohort.

Current

$120.49B

Implied fair

$150.10B

Gap (current − fair)

$-29.61B(-19.7%)

Revenue = $75.05B
Industry P/S = 2×
$75.05B × 2 = $150.10B
  • 산업 평균 PSR 2x 가정
  • 매출 기반 — 적자 기업·신생 기업에 적용 가능
  • 이익률 차이 무시

DCF (Gordon)

Overvalued +26.7%

CF × (1+g) / (r − g)

What it measures · Simplified Gordon-growth DCF — discounting perpetual cash flows. Extremely sensitive to the cash-flow / discount-rate / growth-rate inputs; trust the scenario grid more than the headline number.

How it is computed · FCF × (1+g) / (r − g). FCF preferred from XBRL/DART; falls back to NetIncome, then 5% of Revenue (rough proxy). Discount rate r = risk-free (4%) + equity premium (5%) = 9%. Growth g is EPS YoY clamped to [-2%, +6%], default 3%.

When to trust it · Strongest for steady, predictable businesses. When r-g approaches 0, the denominator blows up; near-perpetuity-growth combos are intentionally voided. Useless for cyclicals (semis, commodities, shipping) where g itself is noise.

Current

$120.49B

Implied fair

$95.08B

Gap (current − fair)

+$25.41B(+26.7%)

FCF = $8.56B
Discount r = 4.0% + 5.0% = 9.0%
Growth g = -2.0%
$8.56B × (1 + -2.0%) / (9.0% − -2.0%) = $76.24B
  • 현금흐름 입력: FCF (잉여현금흐름)
  • 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
  • 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)

DDM (Gordon)

Overvalued +246.3%

D × (1+g) / (r − g)

What it measures · Values the firm purely on dividends paid to shareholders. Cleanest in theory, but only meaningful when management clearly intends to pay dividends — useless for share-repurchase-only payout policies.

How it is computed · D × (1+g) / (r − g). D from DART alotMatter (배당사항) or |CF dividendsPaid|. If absent, cascades to 30% of NetIncome (typical payout) → 30% of FCF → 1.5% of Revenue. r and g assumptions match DCF.

When to trust it · Most reliable for stable high-yielders (Korean utilities, tobacco, financial holdings). Sharply under-prices buyback-heavy firms (US big tech, parts of Korean IT) — look at the TSY column on the listing page to balance.

Current

$120.49B

Implied fair

$34.79B

Gap (current − fair)

+$85.70B(+246.3%)

Dividend D = $3.13B
Discount r = 9.0%
Growth g = -2.0%
$3.13B × (1 + -2.0%) / (9.0% − -2.0%) = $27.89B
  • 배당 입력: 실제 지급 배당
  • 할인율 9.0%
  • 배당 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)

DCF sensitivity: discount rate × terminal growth

Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.

g \ r7%8%9%10%11%
1%-16.4%-2.4%+11.5%+25.5%+39.4%
2%-31.0%-17.2%-3.4%+10.4%+24.2%
3%-45.3%-31.6%-18.0%-4.3%+9.4%
4%-59.4%-45.8%-32.3%-18.8%-5.2%
5%-73.2%-59.8%-46.4%-32.9%-19.5%

DDM sensitivity: discount rate × dividend growth

Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.

g \ r7%8%9%10%11%
1%+128.6%+166.7%+204.8%+242.9%+281.0%
2%+88.6%+126.4%+164.1%+201.8%+239.6%
3%+49.4%+86.8%+124.2%+161.5%+198.9%
4%+11.0%+48.0%+85.0%+122.0%+159.0%
5%-26.7%+10.0%+46.6%+83.3%+119.9%

All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.

Showing the latest 5 years only

17 years of financials are available for this stock. Unlock the remaining 12 years (10+ year history) with Pro.

Upgrade to Pro · $1.99/mo

In USD millions (per-share figures shown directly) · Financials as of: 2026-01-29

핵심 지표 FY 2025

ROE

74.65%

총주주수익률

5.05%

PER

25.50

PBR

16.21

PSR

1.61

PEG

1.11

EV/EBITDA

14.40

배당수익률

2.56%

ROA

8.38%

부채비율

7.90

유동비율

1.09

매출총이익률

10.15%

영업이익률

10.30%

순이익률

6.69%

EPS

$20.49

BPS

$32.56

실적 추이

📄 SEC Filings

Other filings (80)
4

Insider Transaction

xslF345X06/doc4.xml

2026-08-17

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-08-13

Open →

144

144

xsl144X01/primary_doc.xml

2026-08-13

Open →

144

144

xsl144X01/primary_doc.xml

2026-08-12

Open →

144

144

xsl144X01/primary_doc.xml

2026-08-11

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-08-04

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-07-02

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-07-02

Open →

11-K

11-K

11-K

2026-06-24

Open →

11-K

11-K

11-K

2026-06-24

Open →

11-K

11-K

11-K

2026-06-24

Open →

11-K

11-K

11-K

2026-06-24

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-06-15

Open →

3

3

xslF345X06/doc3.xml

2026-06-10

Open →

SD

SD

SD

2026-05-27

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X02/primary_doc.xml

2026-04-30

Open →

S-3ASR

S-3ASR

S-3ASR

2026-04-23

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-04-06

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-04-02

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-04-02

Open →

4

Insider Transaction

xslF345X06/doc4.xml

2026-04-02

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X02/primary_doc.xml

2026-03-27

Open →

ARS

ARS

ARS

2026-03-26

Open →

DEFA14A

DEFA14A

DEFA14A

2026-03-26

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-03-13

Open →

144

144

xsl144X01/primary_doc.xml

2026-03-11

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-27

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-27

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-24

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-24

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-02-18

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-01-05

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2026-01-05

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-12-09

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-12-09

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-12-09

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-12-09

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-12-09

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-10-28

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-10-27

Open →

144

144

xsl144X01/primary_doc.xml

2025-10-23

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-10-02

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-10-02

Open →

424B2

424B2

424B2

2025-07-24

Open →

FWP

FWP

FWP

2025-07-23

Open →

424B5

424B5

424B5

2025-07-23

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-07-02

Open →

4

Insider Transaction

xslF345X05/doc4.xml

2025-07-02

Open →

11-K

11-K

11-K

2025-06-24

Open →

11-K

11-K

11-K

2025-06-24

Open →

11-K

11-K

11-K

2025-06-24

Open →

11-K

11-K

11-K

2025-06-24

Open →

SD

SD

SD

2025-05-28

Open →

PX14A6G

PX14A6G

BOWYER RESEARCH - PX14A6G

2025-05-08

Open →

3

3

xslF345X02/doc3.xml

2025-04-25

Open →

DEFA14A

DEFA14A

DEFA14A

2025-04-08

Open →